Enhancing Drug Synergy Prediction through Multi-Omics Integration and Attention-Based Graph Neural Networks

Abstract Predicting synergistic drug combinations is an important task in precision oncology, but accurately modeling the heterogeneous molecular characteristics of cancer cell lines and the interactions between drugs remains challenging. In this study, we propose GraOmicSynergy, a graph-based deep learning framework that integrates multi-omics representations of cell lines with molecular graph representations of drug pairs. Cell-line omics data, including gene expression, mutation and copy number aberration, and methylation, are encoded using modality-specific convolutional neural networks, while individual drugs are represented as molecular graphs. An attention-based drug-pair mechanism is employed to model the context-dependent contributions of individual drugs within a combination, and the resulting representations are integrated to predict drug synergy scores. We evaluate GraOmicSynergy using five-fold cross-validation under Mixed-set, Blind-Cellline, and Blind-DrugPair scenarios, with comparisons against DeepSynergy and DeepDDS. The results show that GraOmicSynergy-GE outperforms both baseline methods in the Mixed-set and Blind-Cellline scenarios, achieving lower RMSE and higher Pearson correlation, with statistically supported differences across the evaluated metrics, whereas prediction of completely unseen drug pairs remains substantially more challenging. For the complementary classification task, GraOmicSynergy achieves the highest values for four of six metrics in both the Mixed-set and Blind-Cellline scenarios. Multi-omics analysis indicates that the predictive benefit of additional modalities is configuration- and scenario-dependent, with more evident gains in the Mixed-set setting. An ablation study further shows that attention-based drug-pair fusion provides consistently higher Pearson correlation than concatenation and mean pooling across the evaluated omics configurations. Additional classification and tissue-specific analyses were conducted to characterize model performance across different settings. Overall, the findings support GraOmicSynergy as a context-aware framework for drug synergy prediction, while highlighting the need for independent validation to establish broader generalizability.

Authors

Institutions

Publication Details

Journal
Biology Methods and Protocols
Published
2026-11-16
DOI
https://doi.org/10.1093/biomethods/bpag063
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Enhancing Drug Synergy Prediction through Multi-Omics Integration and Attention-Based Graph Neural Networks

Duc‐Hau Le, Hoa Dinh Vu, Giang T.T. Nguyen
Biology Methods and Protocols
Computational Drug Discovery Methods
article

Enhancing Drug Synergy Prediction through Multi-Omics Integration and Attention-Based Graph Neural Networks

Duc‐Hau Le, Hoa Dinh Vu, Giang T.T. Nguyen
article en

Abstract

Abstract Predicting synergistic drug combinations is an important task in precision oncology, but accurately modeling the heterogeneous molecular characteristics of cancer cell lines and the interactions between drugs remains challenging. In this study, we propose GraOmicSynergy, a graph-based deep learning framework that integrates multi-omics representations of cell lines with molecular graph representations of drug pairs. Cell-line omics data, including gene expression, mutation and copy number aberration, and methylation, are encoded using modality-specific convolutional neural networks, while individual drugs are represented as molecular graphs. An attention-based drug-pair mechanism is employed to model the context-dependent contributions of individual drugs within a combination, and the resulting representations are integrated to predict drug synergy scores. We evaluate GraOmicSynergy using five-fold cross-validation under Mixed-set, Blind-Cellline, and Blind-DrugPair scenarios, with comparisons against DeepSynergy and DeepDDS. The results show that GraOmicSynergy-GE outperforms both baseline methods in the Mixed-set and Blind-Cellline scenarios, achieving lower RMSE and higher Pearson correlation, with statistically supported differences across the evaluated metrics, whereas prediction of completely unseen drug pairs remains substantially more challenging. For the complementary classification task, GraOmicSynergy achieves the highest values for four of six metrics in both the Mixed-set and Blind-Cellline scenarios. Multi-omics analysis indicates that the predictive benefit of additional modalities is configuration- and scenario-dependent, with more evident gains in the Mixed-set setting. An ablation study further shows that attention-based drug-pair fusion provides consistently higher Pearson correlation than concatenation and mean pooling across the evaluated omics configurations. Additional classification and tissue-specific analyses were conducted to characterize model performance across different settings. Overall, the findings support GraOmicSynergy as a context-aware framework for drug synergy prediction, while highlighting the need for independent validation to establish broader generalizability.

Biology Methods and Protocols
Trường Đại học Khoa học và Công nghệ Hà Nội (VN), Hanoi University of Science and Technology (VN)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon